Point72 Asset Management, L.P.

Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol
IKT on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

Point72 Asset Management, L.P. ownership in Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

14 Feb 2025 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT). This represents 0% ownership of the company. This is the first filing by Point72 Asset Management, L.P. disclosing ownership of Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT).